Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

1 result

  • Active substance : infliximab
  • Topics : Diseases and conditions
  • Topics : Joint and rheumatic diseases
  • Topics : Organisation of care
Filter
Topic
  • Economics and public health (1)
  • Plus ...
    • Organisation of care (1)
    • Health economics (1)
    • Occupational health (1)
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Therapeutic patient education (1)
    • Nutrition, dietetics (1)
    • Alternative medicine (1)
    • Rehabilitation techniques (1)
  • Diseases and conditions (1)
  • Plus ...
    • Immune system diseases (1)
    • Plus ...
      • Autoimmune diseases (1)
    • Musculoskeletal diseases (1)
    • Plus ...
      • Joint and rheumatic diseases (1)
Content type
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Practice guidelines (1)
Manufacturer
  • industriels (1)
Language
  • Français (1)
Active substance
  • adalimumab (1)
  • alcool (1)
  • argent (1)
  • etanercept (1)
  • graphite (1)
  • hydrocortisone (1)
  • infliximab (1)
  • prednisolone (1)
  • prednisone (1)
  • zinc (1)
 More filter Other Filter Icon
Search Export

Practice guidelines and other guides - 1 result

  • Rheumatoid arthritis: Medical, social and organisational aspects of treatment (excluding surgery and drugs)

    Practice guidelines - Posted on 21/5/2007 - Mis à jour le 19/12/2008
    Download abstract
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
Sx7UAVPjxm9c97KM